Report on the Early Efficacy and Tolerability of I125 Permanent Prostate Brachytherapy from a UK Multi-institutional Database
Keywords: Database; prostate brachytherapy; PSA;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer
Keywords: Cdx2; Cytokeratin; Immunohistochemistry; Prostate cancer; PSA; TTF1
PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
Keywords: genes; neoplasm; prostatic neoplasms; prostate-specific antigen; DRE; digital rectal examination; GS; Gleason score; NPV; negative predictive value; PCA3; prostate cancer gene 3; PPV; positive predictive value; PSA; prostate specific antigen; TRUS; transr
Surveillance biologique du PSA, des marqueurs neuroendocrines et de la testostérone chez des patients porteurs de cancer localisé de la prostate traités par radiothérapie
Keywords: Total and free PSA; Chromogranin A; NSE; Prostate cancer; Radiotherapy; PSA; Chromogranine A; NSE; Cancer de la prostate; Radiothérapie;
Détection des différentes formes du prostate-specific antigen et autres kallicréines dans le cancer de la prostate
Keywords: Cancer de la prostate; Diagnostic; Marqueurs tumoraux; PSA; KallicréinesProstate cancer; Diagnosis; Tumor markers; PSA; Kallikreins
The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
Keywords: prostate; prostatic neoplasms; cholestenone 5 alpha-reductase; androgens; dihydrotestosterone; 5αR; 5α-reductase; ADI; androgen depletion independent; AR; androgen receptor; ARE; androgen response element; BPH; benign prostatic hyperplasia; DHT; dihydro
Multidimensional approaches in dealing with prostate cancer
Keywords: AR; androgen receptor; ARE; androgen response element; CaP; carcinoma of prostate; CBP; Creb-Binding Protein; CPA; cyproterone acetate; CT; computed tomography; EDT; estrogen deprivation therapy; ER; estrogen receptor; GM-CSF; granulocyte macrophage colon
Prostatectomies totales rétropubiennes, laparoscopiques et robot-assistées : comparaison des suites postopératoires, des résultats anatomopathologiques et fonctionnels : à propos de 86 prostatectomies
Keywords: Prostate; Cancer de prostate; Prostatectomie; Laparoscopie; Robotique chirurgicale; Da Vinci; PTRP; prostatectomie totale retropubienne; PTL; prostatectomie totale laparoscopique; PTLRA; prostatectomie totale laparoscopique robot-assistée; PSA; antigène
The use of PSA as biomarker in nutritional intervention studies of prostate cancer
Keywords: Chemoprevention; Prostate cancer; PSA; Xenograft models;
Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer
Keywords: Polymorphism; Androgen receptor; CAG repeats; PSA; Prostate cancer; SRD5A2; CYP17
A novel technique for the characterization of a HPGe detector response based on pulse shape comparison
Keywords: Gamma-rays; HPGe detectors; Pulse shape analysis; PSA; AGATA; Detector scan
Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions
Keywords: P. sepium Bge; PSA; ConA-induced hepatitis; NKT cell
Accelerated synthesis of all-silica DD3R and its performance in the separation of propylene/propane mixtures
Keywords: DD3R; Zeolite; Clathrasil; Propane; Propylene; Separation; PSA; Binary adsorption
High-Dose-Rate Brachytherapy in the Curative Treatment of Patients With Localized Prostate Cancer
Keywords: AUA; American Urological Association; CT; computed tomography; HDR; high-dose-rate; LDR; low-dose-rate; PSA; prostate-specific antigen; RT; radiotherapy; TRUS; transrectal ultrasound; TURP; transurethral resection of the prostate;
Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions
Keywords: PSA; Prostate-specific antigen; f-PSA; free-PSA; T-PSA; tissue-PSA; TIC; Thiophilic Interaction Chromatography; T-gel; Thiophilic-gel; ELISA; Enzyme-linked immunosorbant assay; SDS/PAGE; sodium dodecylsulfate/polyacrylamide gel electrophoresis; PSA-ACT; P
Questionnaire order significantly increased response to a postal survey sent to primary care physicians
Keywords: Response rate; Factorial trial; Questionnaire order; Precontact; Physicians; General practitioner; PSA
Diet and Dietary Supplement Intervention Trials for the Prevention of Prostate Cancer Recurrence: A Review of the Randomized Controlled Trial Evidence
Keywords: diet; dietary supplements; prostatic neoplasms; recurrence; BMI; body mass index; HRPC; hormone refractory prostate cancer; PSA; prostate specific antigen; PSADT; prostate specific antigen doubling time; RCT; randomized, controlled trial;
PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database
Keywords: Biochemical recurrence; Prostate cancer; PSA; Radical prostatectomy
Serum Markers for Prostate Cancer: A Rational Approach to the Literature
Keywords: Biomarkers; Prostate cancer; PSA; Screening;
Optimisation de l’utilisation du PSA
Keywords: PSA; PSA libre; PSA complexé; Pro-PSA; Cinétique tumorale; Vélocité; Calcul de risquePSA; Free PSA; Complexed PSA; Pro-PSA; Kinetic parameters; Velocity; Cancer risk algorithm
Early Detection of Prostate Cancer in 2007: Part 1: PSA and PSA Kinetics
Keywords: Prostate cancer; PSA; PSA velocity; Screening; Risk stratification
A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally
Keywords: Allergy and inflammation; anaphylactic shock; degranulation; druglike compound; mast cells/basophils; tyrosine kinase; Syk; BMMC; Bone marrow-derived mast cell; C-13; Compound 13; ITAM; Immunoreceptor tyrosine-based activation motif; LAT; Linker for act
Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer
Keywords: L-Dopa decarboxylase; DDC; Prostate cancer; Tumor biomarkers; PSA; Real-time PCR; LNCaP; PC3
Optimization of PSA process for producing enriched hydrogen from plasma reactor gas
Keywords: PSA; Purification; Hydrogen and methane; Adsorption; Optimization; gPROMS; Plasma process
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Keywords: prostatic neoplasms; gonadotropin-releasing hormone agonists; cardiovascular diseases; diabetes mellitus; obesity; ADA; American Diabetes Association; ADT; androgen deprivation therapy; AHR; adjusted hazard ratio; BMI; body mass index; CaPSURE; Cancer of
Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
Keywords: Golm1; Golgi membrane protein 1; PSA; prostate-specific antigen; PIN; prostatic intraepithelial neoplasia; BPH; benign prostatic hyperplasia; LCM; laser capture microdissection;
Polysialylated NCAM Represses E-Cadherin-Mediated Cell-Cell Adhesion in Pancreatic Tumor Cells
Keywords: EGFP; enhanced green fluorescence protein; endo-N; endoneuraminidase-N; NCAM; neural cell adhesion molecule; PSA; polysialic acid; PSA-NCAM; polysialylated neural cell adhesion molecule;
Asymmetric information and contract design for payments for environmental services
Keywords: CRP; Conservation Reserve Program; EPD; Environmental Protection Division; MAO; maximum acceptable offer; PES; payments for environmental services; PSA; Programa de Pagos de Servicios Ambientales; Asymmetric information; Environmental services; Contracts;
A mouse Fcγ-Fcε protein that inhibits mast cells through activation of FcγRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases
Keywords: FcγRIIB; mast cell inhibition; FcεRI signaling; BMMC; Bone marrow-derived mast cells; DNP; Dinitrophenyl; ERK; Extracellular signal-regulated kinase; hGE2; Human GE2; ITIM; Immunoreceptor tyrosine-based inhibitory motif; mGE; Mouse homolog of human GE
Prostate cancer staging tables—A predictive model for the UK
Keywords: Prostate cancer; Nomogram; Predictive; Radical prostatectomy; Gleason score; PSA; Positive cores; Outcome
Hierarchical Changepoint Models for Biochemical Markers Illustrated by Tracking Postradiotherapy Prostate-Specific Antigen Series in Men With Prostate Cancer
Keywords: Bayesian Models; Hierarchical Changepoint Models; Longitudinal Data; Biomarkers; PSA; Prostate Cancer; RadiotherapyPSA, prostate-specific antigen; BHC, Bayesian hierarchical changepoint
Key attributes of the SAPHIRE risk and reliability analysis software for risk-informed probabilistic applications
Keywords: Risk-informed; PRA; PSA; Probability; Risk assessment; Safety; Reliability; Software; SAPHIRE; Analysis
Level-1 probability safety assessment of the Iranian heavy water reactor using SAPHIRE software
Keywords: PSA; Heavy water; Reactor; SAPHIRE; Probability; Safety
Précurseurs et dérivés du PSA : application en clinique, revue de la littérature
Keywords: PSA; Dérivés PSA; Cancer prostate; HBP; ProPSA; BPSA; PSA; Prostate cancer; BPH; ProPSA; BPSA;
Effect of Statin Therapy on Early Return of Potency After Nerve Sparing Radical Retropubic Prostatectomy
Keywords: prostate; prostatic neoplasms; prostatectomy; impotence; hydroxymethylglutaryl-CoA reductase inhibitors; ED; erectile dysfunction; IIEF; International Index of Erectile Function; LDL; low density lipoprotein; PDE5; phosphodiesterase 5; PSA; prostate speci
Effect of Intraprostatic Local Anesthesia During Transrectal Ultrasound Guided Prostate Biopsy: Comparison of 3 Methods in a Randomized, Double-Blind, Placebo Controlled Trial
Keywords: prostate; biopsy; pain; prostatic neoplasms; anesthesia; local; PNB; periprostatic nerve block; PSA; serum prostate specific antigen; TRUS; transrectal ultrasound;
Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; age groups; PCa; prostate cancer; PSA; prostate specific antigen; PSAV; PSA velocity;
Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference
Keywords: prostate; prostatic neoplasms; clinical conference [publication type]; ADT; androgen deprivation therapy; CRPC; castration resistant prostate cancer; EBRT; external beam radiation therapy; PSA; prostate specific antigen; PSADT; PSA doubling time; RP; radi
Characterisation of an AGATA symmetric prototype detector
Keywords: 07.85.Nc; 29.30.−h; 29.30.Kv; 29.40.Gxγ-Ray tracking; Digital acquisition; PSA; HPGe detectors; E-field simulation
Does Body Mass Index Affect Preoperative Prostate Specific Antigen Velocity or Pathological Outcomes After Radical Prostatectomy?
Keywords: prostate; prostatic neoplasms; prostatectomy; obesity; BMI; body mass index; PSA; prostate specific antigen; PSAV; PSA velocity;
A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer
Keywords: prostatic neoplasms; drug therapy; docetaxel; vinorelbine; AIPC; androgen independent prostate cancer; CT; computerized tomography; EMP; estramustine phosphate; PSA; prostate specific antigen; TTP; time to progression;
Is the GPSM Scoring Algorithm for Patients With Prostate Cancer Valid in the Contemporary Era?
Keywords: prostate; prostatic neoplasms; nomograms; mortality; prostatectomy; BCR; biochemical recurrence; C index; Harrell's measure of concordance; GPSM; Gleason, PSA, seminal vesicle and margin status; PSA; prostate specific antigen; RRP; radical retropubic pr
Importance of Tumor Location in Patients With High Preoperative Prostate Specific Antigen Levels (Greater Than 20 ng/ml) Treated With Radical Prostatectomy
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; prostatectomy; neoplasm recurrence; local; PSA; prostate specific antigen;
Salvage Cryoablation of the Prostate: Followup and Analysis of Predictive Factors for Outcome
Keywords: cryosurgery; prostatic neoplasms; prostate-specific antigen; recurrence; PSA; prostate specific antigen; RT; radiotherapy;
A Preliminary Study of JM-27: A Serum Marker That Can Specifically Identify Men With Symptomatic Benign Prostatic Hyperplasia
Keywords: prostatic hyperplasia; urinary tract; biological markers; immunoassay; AUA; American Urological Association; BPH; benign prostatic hyperplasia; BSA; bovine serum albumin; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; LUTS; lower
Detection of Sentinel Node Micrometastasis by Step Section and Immunohistochemistry in Patients With Prostate Cancer
Keywords: prostate; lymph nodes; prostatic neoplasms; radionuclide imaging; neoplasm metastasis; CT; computerized tomography; IHC; immunohistochemistry; LN; lymph node; NHT; neoadjuvant hormone therapy; PSA; prostate specific antigen; SN; sentinel node; SPECT; sing
The Association Between Total Prostate Specific Antigen Concentration and Prostate Specific Antigen Velocity
Keywords: prostate-specific antigen; prostatic neoplasms; drug screening assays; antitumor; DRE; digital rectal examination; PSA; prostate specific antigen; PSAV; prostate specific antigen velocity;
Prostate Specific Antigen Only Androgen Independent Prostate Cancer: Natural History, Challenges in Management and Clinical Trial Design
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; receptors; androgen; AIPC; androgen independent prostate cancer; AR; androgen receptor; ECOG; Eastern Cooperative Oncology Group; PSA; prostate specific antigen;
Contrast Enhanced Ultrasound Flash Replenishment Method for Directed Prostate Biopsies
Keywords: prostate; prostatic neoplasms; ultrasonography; biopsy; microbubbles; HI; harmonic imaging; MFI; MicroFlow Imaging; PSA; prostate specific antigen;
Hereditary angioedema: Safety of long-term stanozolol therapy
Keywords: Hereditary angioedema; attenuated androgens; stanozolol; side effects; HAE; Hereditary angioedema; PSA; Prostate specific antigen;